[Form 4] Clene Inc. Insider Trading Activity

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Clene Inc. director Arjun JJ Desai reported an award of stock options. On February 19, 2026, he received an option grant for 3,168 shares of common stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.73 per share. The footnote states these options vest immediately upon grant, giving him the right to purchase Clene shares at that price going forward.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Desai Arjun JJ

Role Director

Type	Security	Shares	Price	Value
Grant/Award	stock option	3,168	$0.00	--

Holdings After Transaction: stock option — 3,168 shares (Direct)

Footnotes (1)

[object Object]

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 02/20/2026 - 04:03 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Desai Arjun JJ

(Last)

(First)

(Middle)

6550 SOUTH MILLROCK DRIVE

SUITE G50

(Street)

SALT LAKE CITY

84121

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Clene Inc. [ CLNN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/19/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
stock option	$4.73	02/19/2026		A		3,168		⁽¹⁾	02/18/2036	common stock	3,168	$0	3,168	D

Explanation of Responses:

1. This option was granted on February 19, 2026 as an option for 3,168 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.73 per share. The options vest immediately upon grant.

	/s/ Jerome T. Miraglia POA	02/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Clene Inc. (CLNN) report for Arjun JJ Desai?

Clene Inc. reported that director Arjun JJ Desai received a grant of stock options for 3,168 shares. The options were awarded on February 19, 2026 under the Amended 2020 Stock Plan and give him the right to buy shares at a fixed exercise price.

How many Clene Inc. (CLNN) stock options were granted to Arjun JJ Desai?

Arjun JJ Desai was granted stock options covering 3,168 shares of Clene Inc. common stock. According to the Form 4, this entire amount was acquired in a single award, and his total derivative holdings following the transaction are reported as 3,168 stock options.

What is the exercise price of the Clene Inc. (CLNN) options granted to Arjun JJ Desai?

The stock options granted to Arjun JJ Desai carry an exercise price of $4.73 per share. This means he can purchase up to 3,168 Clene Inc. common shares at $4.73 each, regardless of future market prices, as long as the options remain outstanding.

When did the new Clene Inc. (CLNN) stock options for Arjun JJ Desai vest?

The footnote explains that the options granted to Arjun JJ Desai vest immediately upon grant. This immediate vesting on February 19, 2026 allows him to exercise the 3,168 options at any permitted time under plan and award terms, subject to standard restrictions.

Under which plan were the Clene Inc. (CLNN) options for Arjun JJ Desai granted?

The options for Arjun JJ Desai were granted under the Clene Inc. Amended 2020 Stock Plan. This plan governs the terms of equity awards such as stock options, including exercise price, vesting provisions, and other conditions affecting how and when awards can be exercised.

How many Clene Inc. (CLNN) derivative securities does Arjun JJ Desai hold after this grant?

After the reported transaction, Arjun JJ Desai holds 3,168 derivative securities in the form of stock options. The Form 4 states this figure explicitly as the total number of options beneficially owned following the grant transaction reported on February 19, 2026.